Vienna Stock Exchange News

First trading day of Biogena Group Invest in the direct market

(Vienna) The Vienna Stock Exchange reports a new addition to its entry segment "direct market". From today, shares of Biogena Group Invest AG can be traded exclusively on the Vienna Stock Exchange. BAADER BANK AG Wertpapierhandelsbank is the responsible Market Maker in continuous trading. Biogena Group Invest AG is the issuing company of the central operating Biogena Group Invest GmbH & Co KG. The Salzburg-based family business develops, produces and markets micronutrient products made in Austria with high quality standards as well as integrated solutions in the field of workplace health promotion. 

 

For further information, please contact:

Julia Resch

Julia Resch

Head of Corporate Communications & Marketing, Spokesperson

julia.resch(a)wienerboerse.at
+43 1 531 65-186

Maria Zorn

Maria Zorn

Media Relations Manager

maria.zorn(a)wienerboerse.at
+43 1 531 65-110


About Wiener Börse AG

As the main provider of market infrastructure in the region, Wiener Börse AG is the gate to global markets. Operating the stock exchanges in Vienna and Prague, the group offers state-of-the-art systems, information and IT services. Listed companies receive maximum liquidity and investors benefit from fast and cost-effective trading by the market leader. Wiener Börse AG also collects and distributes stock market data and calculates the most important indices of the region. Because of this unique know-how the national stock exchanges in Budapest, Ljubljana and Zagreb trust its IT services. Additionally, the group holds stakes in energy exchanges and clearing houses. 

Exclusion of Liability

This press release may contain certain forward-looking statements and forecasts that are based on assumptions current made at the time of publication of this press release. We do not assume any liability for these forward-looking statements materializing. Furthermore, we would like to explicitly point out that this press release cannot serve as a basis for investment decisions and may not be construed as a solicitation to buy or a recommendation to invest by Wiener Börse AG. No liability is assumed for the information given in this press release.

Price Information

Biogena Group Invest AG